Tvardi Therapeutics, Inc.

Nasdaq:TVRD

Pharmaceutical Preparations·SUGAR LAND, TX

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

20 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
5/13/24	Q2 FY2024	→
3/4/24	Q1 FY2024	→
11/13/23	Q4 FY2023	→
↓

News (8-K)

60 shown

Filed	Type	Description
3/6/26	Other	Other Events	→
1/16/26	Reg FD	Regulation FD Disclosure	→
12/18/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/19/25	Reg FD	Regulation FD Disclosure	→
10/14/25	Other	Other Events	→
7/14/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
3/6/26	424B3	424B3	→
11/13/25	424B3	424B3	→
10/20/25	S-8	S-8	→
10/20/25	S-1/A	S-1/A	→
10/7/25	S-1/A	S-1/A	→
5/30/25	S-1	S-1	→
↓

Filing History(780 filings)

TypeDateAccessionPeriodSize

424B3

Mar 6, 2026

0001104659-26-024686424B3

—

68.4 KB

8-K

Mar 6, 2026

0001104659-26-024676FORM 8-K

Mar 6, 2026

188.7 KB

SCHEDULE 13G/A

Feb 17, 2026

0001486420-26-000003

—

8.5 KB

Feb 2, 2026

0002064889-26-000002

Jan 29, 2026

5.6 KB

Feb 2, 2026

0002064982-26-000002

Jan 29, 2026

5.6 KB

Feb 2, 2026

0002064881-26-000002

Jan 29, 2026

5.6 KB

Feb 2, 2026

0002064884-26-000002

Jan 29, 2026

5.7 KB

8-K

Jan 16, 2026

0001104659-26-004273FORM 8-K

Jan 16, 2026

6.8 MB

8-K

Dec 18, 2025

0001104659-25-122615FORM 8-K

Dec 16, 2025

201.8 KB

Dec 18, 2025

0002064889-25-000003

Dec 16, 2025

5.7 KB

Dec 18, 2025

0002064881-25-000003

Dec 16, 2025

5.7 KB

Dec 18, 2025

0002064982-25-000003

Dec 16, 2025

5.7 KB

Dec 18, 2025

0002064884-25-000003

Dec 16, 2025

5.7 KB

8-K

Nov 19, 2025

0001104659-25-113901FORM 8-K

Nov 19, 2025

5.5 MB

SCHEDULE 13G/A

Nov 14, 2025

0001486420-25-000007

—

8.3 KB

424B3

Nov 13, 2025

0001104659-25-111336424B3

—

1.5 MB

8-K

Nov 13, 2025

0001104659-25-111310FORM 8-K

Nov 13, 2025

289.8 KB

10-Q

Nov 13, 2025

0001104659-25-11128910-Q

Sep 30, 2025

8.9 MB

S-8

Oct 20, 2025

0001104659-25-100898FORM S-8

—

263.0 KB

S-1/A

Oct 20, 2025

0001104659-25-100896S-1/A

—

5.2 MB

8-K

Oct 14, 2025

0001104659-25-098908FORM 8-K

Oct 13, 2025

219.5 KB

S-1/A

Oct 7, 2025

0001104659-25-097519S-1/A

—

19.7 MB

8-K

Aug 14, 2025

0001104659-25-078665FORM 8-K

Aug 14, 2025

272.6 KB

SCHEDULE 13G

Aug 14, 2025

0000902664-25-003656

—

22.5 KB

10-Q

Aug 14, 2025

0001558370-25-01156210-Q

Jun 30, 2025

8.7 MB

25 filings shown

Filed	Form	Description
4/22/24	DEFA14A	DEFA14A	→
4/22/24	DEF 14A	DEF 14A	→
4/12/24	PRE 14A	PRE 14A	→
4/20/23	DEFA14A	DEFA14A	→
4/20/23	DEF 14A	DEF 14A	→
4/22/22	DEFA14A	DEFA14A	→
↓

Tvardi Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(780 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/2/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
2/2/26	4	4	→
12/18/25	4	4	→
12/18/25	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/14/25	SCHEDULE 13G	SCHEDULE 13G	→
8/8/25	SCHEDULE 13G	SCHEDULE 13G	→
8/5/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/2/25	SCHEDULE 13G	SCHEDULE 13G	→
↓